Skip to content

Trial Summary

This study will collect data related to the management of women and men with HER2 positive metastatic breast cancer who are treated in routine clinical practice.



ACTRN/NCT /ethics:


Scientific title:

Treatment of Advanced Breast Cancer in the Human Epidermal Growth Factor Receptor 2 (HER2) Positive Australian Patient

Sponsor / Cooperative group:

BioGrid Australia Ltd

Trial & Patient Characteristics

Cancer TypeBreast
Trial TypeEarly detection, diagnosis, prognosis
Age Range18 years and older
Tumour Stream Breast
Cancer StageMetastatic or Widespread
Anticipated Start Date2015-30-10
Anticipated End Date-

Participating Hospitals

HospitalThe Queen Elizabeth Hospital
Clinical Trial CoordinatorPamela Cooper
Phone08 8222 6140
Principal InvestigatorDr Amanda Townsend
Recruitment StatusNot Yet Recruiting